An NIH-funded study of 40 human postmortem hippocampal samples, spanning ages 20 to 95, has found that the brain’s resident ...

Aging of the central nervous system is characterized by intricate changes in immune regulation, molecular signaling, and ...

BCG vaccine triggers immune remodeling in the cerebrospinal fluid and reduces Alzheimer's disease biomarkers in older adults.

Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused biotechnology company developing therapies that reprogram cancer biology, restore anti-tumor immunity and overcome treatment resistance, ...

A new approach to Alzheimer’s research successfully restored two hours of sleep for subjects and could become a tool for early detection and slowing progress of the disease, researchers at ...

A breakthrough by a UK research team could shift the way sleep loss is treated for patients with Alzheimer’s disease.

Concrete: Stars Over Sand #2 finds our hero lost in the desert with amnesia while Maureen frantically organizes a search ...

A single-cell study revealed widespread remodeling of immune cells, three-dimensional genome architecture, and gene ...

New research found that aging triggers a dramatic shift in brain immune cells, weakens the blood-brain barrier, and disrupts genome organization, highlighting potential targets for dementia research.

The data shows that the brain's primary immune cells decline from age 50 to 75 years and are replaced with elevated inflammatory signatures.

Metastasis remains the leading cause of cancer-related death, yet therapeutic progress continues to lag behind advances in our understanding of primary ...

A University of Arizona researcher is exploring how the gut communicates directly with the brain in hopes of changing how ...